Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- Check3 days agoChange DetectedThe web page has updated its contact information, replacing the previous principal investigator Joel A. Kaplan with Stephanie M. Villeneuve, and has introduced a service alert regarding planned maintenance starting July 25th.SummaryDifference1.0%
- Check10 days agoChange DetectedThe webpage has added new contact information for multiple principal investigators and updated the last posted date, while removing outdated information regarding the modernization of ClinicalTrials.gov data and previous update dates.SummaryDifference1%
- Check17 days agoChange DetectedThe webpage has updated its contact information for multiple principal investigators and added new recruiting dates, while removing outdated dates and a status of 'Suspended'.SummaryDifference0.8%
- Check24 days agoChange DetectedThe modernization of the ClinicalTrials.gov data ingest has been updated to July 2025, and several principal investigators and their contact information have been removed from the page.SummaryDifference4%
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.